Evidence map›Paper›PMID 42022441›Full record

ArticleNature and science of sleep2026

Multidimensional Sleep Health and Sleep Environment Factors in Individuals with Cancer Undergoing Outpatient Chemotherapy: An Exploratory Cross-Sectional Analysis.

Sam Adams, Timothy D Clay, Arman Hasani, Mitchell Turner, Travis Cruickshank

Abstract read
In one paragraph

Article in Nature and science of sleep, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sam AdamsSchool of Medical and Health Sciences, Edith Cowan University, Perth, WA, Australia.ORCID 0000-0002-2895-5971
Timothy D ClaySchool of Medical and Health Sciences, Edith Cowan University, Perth, WA, Australia.
Arman HasaniOncology West, Joondalup Health Campus, Perth, WA, Australia.
Mitchell TurnerSchool of Medical and Health Sciences, Edith Cowan University, Perth, WA, Australia.
Travis CruickshankSchool of Medical and Health Sciences, Edith Cowan University, Perth, WA, Australia.ORCID 0000-0001-8673-191X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Sleep problems are common amongst individuals with cancer receiving chemotherapy and are associated with poorer health outcomes. Considerable research to date has investigated specific sleep domains or symptomology, with little attention given to overall sleep health, which is more closely associated with overall health. This exploratory cross-sectional study aimed to characterize multidimensional sleep health in individuals with cancer reporting sleep complaints whilst undergoing chemotherapy, with exploratory examination of environmental associations. Patients and Methods: Twenty-three participants were included in this exploratory cross-sectional analysis. Participants were diagnosed with cancer within the last 6 months, undergoing outpatient chemotherapy at time of study entry and reported poor sleep quality and/or insomnia symptoms per the Pittsburgh Sleep Quality Index and Insomnia Severity Index. Multidimensional sleep health (duration, continuity, timing, regularity, rhythmicity, sleepiness/alertness, quality) and sleep environmental factors were assessed using sleep questionnaires, wrist-worn actigraphy and a temperature/light data logger. Linear regressions models were used to explore the association between sleep health and sleep environment factors. Results: Examination of multidimensional sleep health indicated that poor sleep quality (87%) and variable sleep timing (61%) were the most prevalent sleep complaints amongst our sample. Mean sleep health score = 3.17 (± 1.83 SD) suggests that on average, three sleep complaints were experienced by the current sample. There were no significant associations between sleep health (domain and overall) and sleep environment factors. Conclusion: Sleep quality and sleep timing were the primary concerns observed amongst our sample. Future investigations should be adequately powered and longitudinally designed to observe changes in sleep health trajectories and temporal relationships over the course of active treatment. Nevertheless, our preliminary findings provide the foundation for future research exploring sleep health amongst cancer populations and highlight that improving sleep quality and timing should be prioritized amongst individuals undergoing chemotherapy.

Indexed as

oncologysleep disturbancesupportive care

Identifiers

PMID42022441
PMCPMC13098556

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.